Peptide Antibiotics Market Analysis by Disease, by Product Type, by Distribution Channel, by Route of Administration, and by Region - Global Forecast to 2029

The peptide antibiotics market size is estimated to be USD 6,210 million in 2021 and is expected to witness a CAGR of 6.45% during the forecast period 2022-2029. The increasing instances of antibiotic resistance, rising need for peptide antibiotics in hospitals and clinics, increasing the number of product launches and approvals, and a rise in the incidence of illnesses such as bloodstream infections, hospital-acquired infections, and bacterial skin infections are some of the primary market drivers. However, using peptide antibiotics over an extended period of time has a lot of negative side effects are expected to restrain the market growth.

By Disease

Based on Disease, the market is segregated into blood stream infections, skin infections, HABP/VABP, and others. In 2021, the skin infections segment held the highest market share owing to increasing occurrence of bacterial skin illnesses such as carcuncles, impetigo, cellulitis, furuncles, and others, as well as widespread product availability.

By Product Type

On the basis of product type, the market is bifurcated into non-ribosomal synthesized peptide antibiotics and ribosomal synthesized peptide antibiotics. In 2021, the non-ribosomal synthesized peptide antibiotics segment held the highest market share due to the increasing accessibility of antibiotics made through a non-ribosomal synthesis, and rising demand for antibiotics made without ribosomes.

By Distribution Channel

Based on distribution channel, the market is segregated into specialty clinics, hospitals, homecare, and others. In 2021, the hospitals segment held the highest market share owing to Increasing bacterial skin infections and ocular infections are causing doctors to prescribe more peptide antibiotics, and increasing rates of hospital-acquired infections, bloodstream infections, and extended hospital stay.

By Route of Administration

Based on route of administration, the market is categorized into topical, oral, parenteral, and others. In 2021, the parenteral segment held the highest market share due to the availability of a large number of peptide antibiotics in injectable form, efficiency, and better bioavailability from injectable peptide antibiotics.

Regional Markets

In 2021, North America had the greatest share of the market due to the increased antibiotic demand in this region, as well as an expansion in R&D activity in the region, the existence of a vast number of market participants, and strategic actions made by important stakeholders. However, the Asia-Pacific region is predicted to grow at the fastest rate during the projection period owing to the increasing elderly population and rise in patient health consciousness, and a rise in the occurrence of different infectious illnesses.

Competitor Insights

Some of the key players operating in the peptide antibiotics market are Abbott (US), AbbVie Inc (US), Allergan Plc )Ireland), Dr. Reddy’s Laboratories Ltd (India), Fresenius Kabi AG (Germany), GSK (UK), HENGRUI (USA), Lilly (US), Merck (US), Novartis AG (Switzerland), Pfizer (US), Sandoz International GmbH (Germany), Sanofi (France), and Teva Pharmaceutical Industries Ltd. (Israel).

This comprehensive research report focuses on the global and regional market size and forecasts of diverse segments including disease, product type, distribution channel and route of administration from 2022-2029.

Segmentation: Peptide Antibiotics Market Analysis Report 2021-2029

Disease (Revenue, USD Million)

• Blood Stream Infections
• Skin Infections
• HABP/VABP
• Others

Product Type (Revenue, USD Million)

• Non-ribosomal Synthesized Peptide Antibiotics
• Ribosomal Synthesized Peptide Antibiotics

Distribution Channel (Revenue, USD Million)

• Specialty Clinics
• Hospitals
• Homecare
• Others

By Route of Administration (Revenue, USD Million)

• Topical
• Oral
• Parenteral
• Others

By Region (Revenue, USD Million)

North America

• U.S
• Canada

Europe

• Germany
• France
• UK
• Spain
• Italy
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Rest of APAC

Latin America

• Brazil
• Mexico
• Argentina
• Rest of LATAM

Middle East & Africa

• South Africa
• GCC
• Rest of MEA